Smart breathing machines at home could cut hospital visits for COPD patients

NCT ID NCT07679646

First seen Jul 01, 2026 · Last updated Jul 01, 2026

Summary

This study looks at whether adding a home telemonitoring system to standard nighttime breathing support (non-invasive ventilation) can help people with severe COPD and high carbon dioxide levels. About 92 participants will be split into two groups: one using standard home ventilation alone, and another using ventilation plus a device that sends daily data (like air leaks and breathing rates) to their healthcare team. The goal is to see if remote monitoring can prevent severe flare-ups and reduce the number of days spent in the hospital over one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Home non-invasive ventilation with telemonitoring

What this could lead to

If successful, this approach could reduce hospital stays and improve daily life for people with severe COPD, while also lowering healthcare costs.

What could go wrong

This is a relatively small study (92 people) and telemonitoring may not significantly change outcomes. Technical issues or patient non-compliance could also limit effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERCAPNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset Hypercapnia lung disorder respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital General Universitario Gregorio Marañón

    Madrid, Madrid, 28007, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••